Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

scientific article published on 29 April 2020

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/21645515.2020.1749509
P932PMC publication ID7553673
P698PubMed publication ID32347775

P50authorHarvey M. FriedmanQ89912954
P2093author name stringSita Awasthi
Kevin Egan
Lauren M Hook
Alexis Naughton
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 4.0 InternationalQ24082749
P6216copyright statuscopyrightedQ50423863
P921main subjectHerpes simplex virus type 1Q655331
reproductive tract infectionQ54931661
P304page(s)1-5
P577publication date2020-04-29
P1433published inHuman Vaccines & ImmunotherapeuticsQ21072749
P1476titleHerpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

Search more.